SCHEMBL24263128

SCHEMBL24263128

Cc1ccc(C(=O)NC2CCc3n[nH]c(=O)cc3C2)cc1

nearest known ligand 0.47

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 4/20 0.47
NPC1 O15118 3/20 0.47
SMN1; SMN2 Q16637 2/20 0.47
HPGD P15428 2/20 0.47
CYP1A2 P05177 1/20 0.47
CYP2C19 P33261 1/20 0.47
LMNA P02545 1/20 0.40
PAK1 Q13153 1/20 0.39
SMYD3 Q9H7B4 2/20 0.39
CRBN Q96SW2 1/20 0.39
GAA P10253 1/20 0.38
ALDH1A1 P00352 2/20 0.38
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
OPRK1 P41145 1/20 0.38
NAMPT P43490 1/20 0.37
TSHR P16473 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24263084 0.89 KMT2A (0.42) RAB9ANPC1SMN1; SMN2HPGDLMNA
SCHEMBL24263131 0.89 HDAC8 (0.45) LMNAPAK1SMYD3GAANAMPT
SCHEMBL24263090 0.89 NPC1 (0.47) RAB9ANPC1PAK1SMYD3GAA
SCHEMBL24263129 0.89 HDAC8 (0.48) RAB9ANPC1SMYD3
SCHEMBL24263134 0.89 SMYD3 (0.39) RAB9ANPC1SMN1; SMN2CYP1A2CYP2C19
SCHEMBL24263127 0.88 MTNR1A (0.46) RAB9ANPC1SMN1; SMN2CRBNGAA
SCHEMBL24263197 0.88 TAOK1 (0.48) LMNASMYD3CRBNGAAALDH1A1
SCHEMBL24263089 0.88 KDM5A (0.40) RAB9ANPC1SMN1; SMN2LMNASMYD3
SCHEMBL24263079 0.86 TAOK1 (0.40) SMYD3CRBNGAAALDH1A1MTNR1A
SCHEMBL24263227 0.85 HDAC8 (0.42) RAB9ANPC1SMN1; SMN2HPGDCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022040508-A1 COMPOUNDS AND METHODS FOR TREATING AUTOIMMUNE DISORDERS BY TARGETING HLA-DQ2 IMMUNOMOLECULAR THERAPEUTICS, INC. (US) 2022-02-24 WO disclosed